Skip to main content

Advertisement

SpringerLink
Log in

Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

A Correction to this article was published on 26 January 2022

This article has been updated

Abstract

Background

Abnormal ion channel currents caused by myocardial electrical remodeling is one of the main causes of malignant arrhythmias. Glycogen synthase kinase 3β (GSK-3β) is the main therapeutic target following ischemia as it regulates nerve cell channels. However, few studies have investigated its role in myocardial electrical remodeling. The present study aimed to investigate the role of GSK-3β in a rat myocardial infarction (MI)–induced electrical remodeling and potential effects on cardiac ionic channels including KCNJ2/Kir2.1/IK1.

Methods

Ligation of the left anterior descending artery in rats was performed to establish a MI model. The rats were randomly divided into three groups, the sham, MI, and MI + SB group. The animals in the latter group were administered SB216763 (GSK-3β inhibitor) at a dose of 0.6 mg·kg−1·day−1. The ventricular function was assessed by echocardiography, electrocardiography, and histological analysis 7 days post-surgery. Serum was collected to measure lactate dehydrogenase and cardiac troponin I levels, and the mRNA and protein levels of the KCNJ2/Kir2.1/IK1 channel in the heart tissues were assessed. H9c2 cells were cultured to examine the effects of SB216763 on the protein expression of Kir2.1 channel under hypoxic conditions.

Results

The results revealed that SB216763 ameliorated acute cardiac injury and improved myocardial dysfunction. Moreover, SB216763 increased the mRNA and protein expression of Kir2.1 during MI. Furthermore, SB216763 treatment abrogated the decreased expression of Kir2.1 in H9c2 cells under hypoxic conditions.

Conclusions

GSK-3β inhibition upregulates Kir2.1 expression in a rat model of MI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Change history

References

  1. Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–64. https://doi.org/10.1056/NEJMra1606915.

    Article  CAS  PubMed  Google Scholar 

  2. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. https://doi.org/10.21037/atm.2016.06.33.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Roell W, Klein AM, Breitbach M, Becker TS, Parikh A, Lee J, et al. Overexpression of Cx43 in cells of the myocardial scar: correction of post-infarct arrhythmias through heterotypic cell-cell coupling. Sci Rep. 2018;8(1):7145. https://doi.org/10.1038/s41598-018-25147-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Nagini S, Sophia J, Mishra R. Glycogen synthase kinases: moonlighting proteins with theranostic potential in cancer. Semin Cancer Biol. 2019;56:25–36. https://doi.org/10.1016/j.semcancer.2017.12.010.

    Article  CAS  PubMed  Google Scholar 

  5. Saraswati AP, Ali Hussaini SM, Krishna NH, Babu BN, Kamal A. Glycogen synthase kinase-3 and its inhibitors: potential target for various therapeutic conditions. Eur J Med Chem. 2018;144:843–58. https://doi.org/10.1016/j.ejmech.2017.11.103.

    Article  CAS  PubMed  Google Scholar 

  6. Shu Q, Liu J, Liu X, Zhao S, Li H, Tan Y, et al. GABAB R/GSK-3beta/NF-kappaB signaling pathway regulates the proliferation of colorectal cancer cells. Cancer Med. 2016;5(6):1259–67. https://doi.org/10.1002/cam4.686.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Jaworski T. Control of neuronal excitability by GSK-3beta: epilepsy and beyond. Biochim Biophys Acta Mol Cell Res. 1867;2020(9):118745. https://doi.org/10.1016/j.bbamcr.2020.118745.

    Article  CAS  Google Scholar 

  8. Wildburger NC, Laezza F. Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase. Front Mol Neurosci. 2012;5:80. https://doi.org/10.3389/fnmol.2012.00080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. van der Heyden MA, Jespersen T. Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation. Eur J Pharmacol. 2016;771:56–64. https://doi.org/10.1016/j.ejphar.2015.11.026.

    Article  CAS  PubMed  Google Scholar 

  10. Li M, Kanda Y, Ashihara T, Sasano T, Nakai Y, Kodama M, et al. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs. J Pharmacol Sci. 2017;134(2):75–85. https://doi.org/10.1016/j.jphs.2017.05.004.

    Article  CAS  PubMed  Google Scholar 

  11. Li X, Hu H, Wang Y, Xue M, Li X, Cheng W, et al. Valsartan ameliorates KIR2.1 in rats with myocardial infarction via the NF-kappaB-miR-16 pathway. Gene. 2016;590(2):201–9. https://doi.org/10.1016/j.gene.2015.11.047.

    Article  CAS  PubMed  Google Scholar 

  12. Li X, Hu H, Wang Y, Xue M, Li X, Cheng W, et al. Valsartan upregulates Kir2.1 in rats suffering from myocardial infarction via casein kinase 2. Cardiovasc Drugs Ther. 2015;29(3):209–18. https://doi.org/10.1007/s10557-015-6598-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Atha J, Wheatley DW. The mobilising effects of repeated measurement on hip flexion. Br J Sports Med. 1976;10(1):22–5. https://doi.org/10.1136/bjsm.10.1.22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang S, Su X, Xu L, Chang C, Yao Y, Komal S, et al. Glycogen synthase kinase-3beta inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction. J Mol Cell Cardiol. 2020;149:82–94. https://doi.org/10.1016/j.yjmcc.2020.09.009.

    Article  CAS  PubMed  Google Scholar 

  15. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94(7):960–6. https://doi.org/10.1161/01.RES.0000122392.33172.09.

    Article  CAS  PubMed  Google Scholar 

  16. Providencia R, Karim N, Srinivasan N, Honarbakhsh S, Vidigal Ferreira MJ, Goncalves L, et al. Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome. Heart. 2018;104(6):502–8. https://doi.org/10.1136/heartjnl-2017-311673.

    Article  PubMed  Google Scholar 

  17. Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169(3):510–22 e20. https://doi.org/10.1016/j.cell.2017.03.050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lv D, Bai Z, Yang L, Li X, Chen X. Lipid emulsion reverses bupivacaine-induced apoptosis of h9c2 cardiomyocytes: PI3K/Akt/GSK-3beta signaling pathway. Environ Toxicol Pharmacol. 2016;42:85–91. https://doi.org/10.1016/j.etap.2016.01.004.

    Article  CAS  PubMed  Google Scholar 

  19. Liu X, Deng Y, Xu Y, Jin W, Li H. MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1. J Mol Cell Cardiol. 2018;118:133–46. https://doi.org/10.1016/j.yjmcc.2018.03.018.

    Article  CAS  PubMed  Google Scholar 

  20. Abd-Ellah A, Voogdt C, Krappmann D, Moller P, Marienfeld RB. GSK3beta modulates NF-kappaB activation and RelB degradation through site-specific phosphorylation of BCL10. Sci Rep. 2018;8(1):1352. https://doi.org/10.1038/s41598-018-19822-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mankad P, Kalahasty G. Antiarrhythmic drugs: risks and benefits. Med Clin North Am. 2019;103(5):821–34. https://doi.org/10.1016/j.mcna.2019.05.004.

    Article  PubMed  Google Scholar 

  22. Hu XT. HIV-1 Tat-mediated calcium dysregulation and neuronal dysfunction in vulnerable brain regions. Curr Drug Targets. 2016;17(1):4–14. https://doi.org/10.2174/1389450116666150531162212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. James TF, Nenov MN, Wildburger NC, Lichti CF, Luisi J, Vergara F, et al. The Nav1.2 channel is regulated by GSK3. Biochim Biophys Acta. 2015;1850(4):832–44. https://doi.org/10.1016/j.bbagen.2015.01.011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fezai M, Ahmed M, Hosseinzadeh Z, Lang F. Up-regulation of the large-conductance Ca2+-activated K+ channel by glycogen synthase kinase GSK3beta. Cell Physiol Biochem. 2016;39(3):1031–9. https://doi.org/10.1159/000447810.

    Article  CAS  PubMed  Google Scholar 

  25. Scala F, Fusco S, Ripoli C, Piacentini R, Li Puma DD, Spinelli M, et al. Intraneuronal Abeta accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3. Neurobiol Aging. 2015;36(2):886–900. https://doi.org/10.1016/j.neurobiolaging.2014.10.034.

    Article  CAS  PubMed  Google Scholar 

  26. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther. 2007;116(2):173–91. https://doi.org/10.1016/j.pharmthera.2007.06.005.

    Article  CAS  PubMed  Google Scholar 

  27. Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A. Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol. 2009;156(6):885–98. https://doi.org/10.1111/j.1476-5381.2008.00085.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wagner C, Tillack D, Simonis G, Strasser RH, Weinbrenner C. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem. 2010;339(1-2):135–47. https://doi.org/10.1007/s11010-009-0377-x.

    Article  CAS  PubMed  Google Scholar 

  29. Hu Z, Crump SM, Zhang P, Abbott GW. Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction. Cardiovasc Res. 2016;110(2):227–37. https://doi.org/10.1093/cvr/cvw048.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT syndrome: an emerging role for inflammation and immunity. Front Cardiovasc Med. 2015;2:26. https://doi.org/10.3389/fcvm.2015.00026.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhai XW, Zhang L, Guo YF, Yang Y, Wang DM, Zhang Y, et al. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat. PLoS One. 2017;12(5):e0177600. https://doi.org/10.1371/journal.pone.0177600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kushiyama Y, Honjo H, Niwa R, Takanari H, Yamazaki M, Takemoto Y, et al. Partial IK1 blockade destabilizes spiral wave rotation center without inducing wave breakup and facilitates termination of reentrant arrhythmias in ventricles. Am J Physiol Heart Circ Physiol. 2016;311(3):H750–8. https://doi.org/10.1152/ajpheart.00228.2016.

    Article  PubMed  Google Scholar 

  33. Osadchii OE. Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol. Exp Physiol. 2019;104(4):490–504. https://doi.org/10.1113/EP087531.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (No. 81670311).

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China

    Cheng Chang, Shu-Hui Wang, Li-Na Xu, Xue-Ling Su, Yi-Fan Zeng, Li-Rong Zhang & Sheng-Na Han

  2. Basic Medical Department, School of Nursing, Zhengzhou University, Zhengzhou, 450001, China

    Peng Wang

Authors
  1. Cheng Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shu-Hui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li-Na Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xue-Ling Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi-Fan Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li-Rong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sheng-Na Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sheng-Na Han.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chang, C., Wang, SH., Xu, LN. et al. Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats. J Interv Card Electrophysiol 63, 239–248 (2022). https://doi.org/10.1007/s10840-021-00963-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-021-00963-7

Keywords

Search

Navigation